Tony Blair, the former British prime minister, has joined Khosla Ventures as a senior advisor. The announcement was made today during Khosla's annual limited partner meeting. Blair will focus on Khosla's cleantech portfolio. In a formal statement, he said: "I am increasingly and crucially aware of the fact that the answer to these twin challenges -- climate change and energy security -- lies in developing the technological solutions of the future."
4 min read · 24 May 2010
Gaikai Inc., a provider of a cloud-based video game streaming service, has raised more than $10 million in Series B funding. TriplePoint Capital, Rustic Canyon Partners and an undisclosed strategic backer were joined by existing shareholder Benchmark Capital.
4 min read · 24 May 2010
MEMC Electronic Materials Inc. (NYSE: WFR) has agreed to acquire Solaicx Inc., a Santa Clara, Calif.-based maker of silicon wafers for photovoltaic panels. The deal is valued at $66 million in cash, plus up to another $10 million based on incoming investment. Solaix has raised over $50 million in VC funding from D.E. Shaw, Applied Ventures, Big Sky Ventures, Firsthand Capital Management, Labrador Ventures and Greenhouse Capital Partners.
4 min read · 24 May 2010
Biomedical Structures LLC, a Warwick, R.I.-based developer of biomaterials and textiles used in orthopedics, reconstructive surgery and tissue engineering, has raised an undisclosed amount of equity funding from Ampersand Ventures.
3 min read · 24 May 2010
Guardian Analytics Inc., a developer of predictive analytics-based fraud prevention software, has raised $9 million in Series C funding. Sutter Hill Ventures led the round, and was joined by return backer Foundation Capital.
3 min read · 24 May 2010
1 min read · 24 May 2010
Zend Technologies, a Cupertino, Calif.-based provider of software for developing and deploying PHP applications, has raised $9 million in new VC funding. Greylock Partners led the round, and was joined by fellow return backers Azure Capital Partners, Index Ventures, Intel Capital, SAP Ventures and WaldenVC.
3 min read · 24 May 2010
1 min read · 24 May 2010
NormOxys Inc., a Wellesley, Mass.-based developer of drugs that enhance the body’s ability to deliver oxygen to diseased tissues, has raised $17.5 million in Series B funding. Care Capital led the round, and was joined by return backer Index Ventures. The company previously raised $12.5 million.
3 min read · 24 May 2010
2 min read · 21 May 2010
